The World Health Organization (WHO) has added 16 new cancer drugs to its list of essential medicines for low- and middle-income countries. However, cautioned Gilberto Lopes Jr, MD, MBA, scientific ...

Calquence combination therapy showed improved progression-free survival in untreated mantle cell lymphoma patients ineligible for HSCT. Lumakras with Vectibix demonstrated superior progression-free ...

Experts estimate that 54% of bowel cancer cases are preventable ...